This inventor holds 1 USPTO granted patent. Top assignee: Samyang Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Young Kwon Choi: Innovator in Transdermal Drug Delivery Systems
Introduction
Young Kwon Choi is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. His innovative approach focuses on enhancing the effectiveness of analgesic agents.
Latest Patents
Young Kwon Choi holds a patent for a "Transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt." This invention relates to a transdermal drug delivery system designed to improve the delivery of anti-inflammatory analgesic agents. The system includes a backing film, a matrix layer containing active ingredients, and a release liner that is removed before application to the skin. The invention enhances transdermal penetration and adhesion through a matrix layer that combines diclofenac diethylammonium salt with an acrylic polymer, non-ionic surfactants, and other constituents to reduce manufacturing time.
Career Highlights
Young Kwon Choi is associated with Samyang Corporation, where he continues to innovate in the pharmaceutical sector. His work has led to advancements in drug delivery technologies, making significant impacts on patient care and treatment efficacy.
Collaborations
He has collaborated with notable colleagues such as Jin Deog Song and Chul Min Park, contributing to the development of innovative solutions in the field.
Conclusion
Young Kwon Choi's contributions to transdermal drug delivery systems exemplify the importance of innovation in pharmaceuticals. His work not only enhances the effectiveness of treatments but also showcases the potential for advancements in drug delivery technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
